Health
UK launches trial of drug to tackle fatigue in long Covid patients – The Guardian
AXA1125 targets cell power plants that may be dysfunctional in long Covid patients with severe fatigue
Long CovidAXA1125 targets cell power plants that may be dysfunctional in long Covid patients with severe fatigue
The first trial of a drug to target the fatigue and muscle weakness experienced by more than half of people with long Covid has been launched…
Continue Reading
-
Business16 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General13 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General23 hours agoAustralia solved civilisation’s problems
-
Business21 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035